2025
- Selection for Cho-gyeok-cha (Super Gap) Startup 1,000+ Linked Support Program (Jan)
- Establishment of a Corporate R&D Center within the College of Pharmacy, Seoul National University (Jan)
- Beginning IIT Phase 1 clinical trial collaboration with MD Anderson Cancer Center (Sep)
- KRW 500 million in Bridge funding (Dec)
2024
- Korean patent application filed for PLM-103 (Jan)
- Selection for the Cho-gyeok-cha(Super Gap) Startup 1,000 Support Program (Apr)
- IND approval for PLM-102 from the MFDS (Korea) and the U.S. FDA (May)
2023
- Completion of preclinical studies for PLM-102 (Jun)
- Patent applications for PLM-102 filed in 9 countries (Dec)
2022
- Selection as a Bio Core Facility partner by Asan Medical Center, Seoul (Jan)
- Selection for Baby Unicorn 200 Fostering Program (May)
- KRW 5.5 billion in Series A Bridge funding (Dec)
2021
- Selection for the Innovation Startup Package Commercialization Program (Jan)
2020
- Selection for the Big3 Startup R&D Package (Dec)
- KRW 6.5 billion in Series A funding (Dec)
2019
- PeLeMed founded (May)
- Certificate of Venture business (Sep)
- Moved into SEOUL BIOHUB (Nov)
- PLM-102 Patent Application Filing (Dec)
- Technology transfer of PLM-101 and PLM-102 from GIST (Dec)
2022
- ASAN Medical Center Bio Core Facility Funding (Jan)
- IP Voucher Funded by MSS* (March)
- Bio Research Data Funding (April)
- Selected Baby Unicorn 200 Funding (May)
- Series A bridge Funding US$ 3mil. (May)
- Initiated Non Clinical Trial for PLM-102 Candidate
- Initiated Preparation for PLM-401 Phase I trial
2021
- Established Internal Company R&D Lab (Jan)
- Big3 Startup Package Commercialization Funding (Jan)
- IP Voucher Funded by KISTA* (April)
- Bio health Investment-Infra R&D Funding (July)
- PLM-105 selected as NDDP* and Funded by KDDF* (July)
- Licensed In PLM-401 (Dec)
- PLM-401 Phase I IND approved (Dec)
* NDDP: National Drug Development Project
* KDDF: Korea Drug Development Fund
2020
- Moved into Poongjeon Bldg. (Nov)
- Big3 Startup Package R&D Funding (Dec)
- APEX anti tumor PK Advisory Service Funding (Dec)
- Series A Funding US$ 5.5mil. (Dec)
2019
- PeLeMed founded (May)
- Certificate of Venture business (Sep)
- Moved into SEOUL BIOHUB (Nov)
2022
- ASAN Medical Center Bio Core Facility Funding (Jan)
- IP Voucher Funded by MSS* (March)
- Bio Research Data Funding (April)
- Selected Baby Unicorn 200 Funding (May)
- Series A bridge Funding US$ 3mil. (May)
- Initiated Non Clinical Trial for PLM-102 Candidate
- Initiated Preparation for PLM-401 Phase I trial
2021
- Established Internal Company R&D Lab (Jan)
- Big3 Startup Package Commercialization Funding (Jan)
- IP Voucher Funded by KISTA* (April)
- Bio health Investment-Infra R&D Funding (July)
- PLM-105 selected as NDDP* and Funded by KDDF* (July)
- Licensed In PLM-401 (Dec)
- PLM-401 Phase I IND approved (Dec)
* NDDP: National Drug Development Project
* KDDF: Korea Drug Development Fund
2020
- Moved into Poongjeon Bldg. (Nov)
- Big3 Startup Package R&D Funding (Dec)
- APEX anti tumor PK Advisory Service Funding (Dec)
- Series A Funding US$ 5.5mil. (Dec)
2019
- PeLeMed founded (May)
- Certificate of Venture business (Sep)
- Moved into SEOUL BIOHUB (Nov)
2022
- ASAN Medical Center Bio Core Facility Funding (Jan)
- IP Voucher Funded by MSS* (March)
- Bio Research Data Funding (April)
- Selected Baby Unicorn 200 Funding (May)
- Series A bridge Funding US$ 3mil. (May)
- Initiated Non Clinical Trial for PLM-102 Candidate
- Initiated Preparation for PLM-401 Phase I trial
2020
- Moved into Poongjeon Bldg. (Nov)
- Big3 Startup Package R&D Funding (Dec)
- APEX anti tumor PK Advisory Service Funding (Dec)
- Series A Funding US$ 5.5mil. (Dec)
2021
- Established Internal Company R&D Lab (Jan)
- Big3 Startup Package Commercialization Funding (Jan)
- IP Voucher Funded by KISTA* (April)
- Bio health Investment-Infra R&D Funding (July)
- PLM-105 selected as NDDP* and Funded by KDDF* (July)
- Licensed In PLM-401 (Dec)
- PLM-401 Phase I IND approved (Dec)
2019
- PeLeMed founded (May)
- Certificate of Venture business (Sep)
- Moved into SEOUL BIOHUB (Nov)